NDA Regulatory Science Limited, Leatherhead, Surrey, UK.
Drug Saf. 2010 Oct 1;33(10):811-20. doi: 10.2165/11537620-000000000-00000.
Society has been increasingly intolerant of excuses for systems breakdown in many areas of public life. This is hardly surprising given that there is overwhelming evidence behind why processes fail and mistakes are made, and so, based on this evidence, processes should be designed to mitigate risk. The main root cause of many process failures can be attributed to the human factor, which encompasses all those factors that can influence people and their behaviour. Based on experience from other safety-conscious industries, there is a major move to manage the human factor as part of delivery of safety culture in healthcare systems. Since pharmaceutical companies are healthcare companies, it makes sense that the principles underlying a pharmaceutical safety culture are aligned with those of the healthcare sector. A good place to start applying human factor management to a pharmaceutical safety process would be the complex process required to produce a good quality Periodic Safety Update Report (PSUR) on time and to an acceptable format. This can be achieved by a process aimed at building on an ongoing learning cycle through planning, observing if execution matches expectations and learning from mistakes and through the interdependent teamwork of PSUR contributors providing mutual support. Such a framework of teamwork and communication principles can be applied to the entire process for the preparation and submission of PSURs.
社会对公共生活许多领域的系统故障借口越来越不能容忍。鉴于为什么会出现流程故障和错误,以及基于这些证据,应该设计流程来降低风险,这背后有压倒性的证据,因此这种情况并不奇怪。许多流程故障的主要根本原因可以归因于人为因素,人为因素包含了所有可能影响人和他们行为的因素。基于其他具有安全意识的行业的经验,将人为因素作为医疗保健系统中安全文化交付的一部分进行管理是一个重大举措。由于制药公司是医疗保健公司,因此制药安全文化所依据的原则与医疗保健部门一致是合理的。将人为因素管理应用于制药安全流程的一个很好的起点是,需要按时以可接受的格式生成高质量的定期安全性更新报告 (PSUR) 的复杂过程。通过旨在通过规划、观察执行是否符合预期以及从错误中学习来建立持续学习循环的过程,可以实现这一点,并且通过 PSUR 贡献者的相互依存的团队合作提供相互支持。这样的团队合作和沟通原则框架可以应用于 PSUR 的编写和提交的整个过程。